Qiangrong Liang obtained the Ph.D. degree under Dr. Paul Epstein from the University of North Dakota and received a 4-year postdoctoral training by Dr. Jeff Molkentin at Cincinnati Children's Hospital Medical Center. He serves currently as a Scientist and as an Associate Professor in Cardiovascular Health Research Center at Sanford Research/University of South Dakota. His interest has been focused on understanding the cellular and molecular mechanisms that underlie acquired heart disease, cardiac hypertrophy and heart failure. He currently conducts research in three major areas: investigate why diabetic patients and animals are predisposed to heart failure and suggest mechanism-based approach to reduce the susceptibility, investigate why the anticancer drug doxorubicin can cause heart failure and how myocardial homeostasis can be restored by coordinately promoting survival mechanisms and blocking cell death pathways, and explore mechanisms of myocardial protection by caloric restriction and develop drugs that mimic the beneficial effects of caloric restriction.
Biography Updated on 6 December 2011